Action Corindus Vascular Robotics - CVRS

Corindus Vascular Robotics Inc (CVRS) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

4,27

( - )

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

4,27

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers

At a special meeting today, stockholders of Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS) approved the...

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference

Breakfast symposium and conference activities to highlight capabilities of vascular robotic technology and advancements in automation and remote...

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System...

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc. PR Newswire NEW YORK, Aug. 8...

Corindus Reports Second Quarter 2019 Results

Corindus announced today a definitive agreement to be acquired by Siemens Healthineers for approximately $1.1 billion, or $4.28 per share, in an...

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

-- Corindus Stockholders to Receive $4.28 Per Share -- -- All-Cash Transaction Valued at Approximately $1.1 Billion -- Corindus Vascular...

Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today that Mark Toland...

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release...

Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities

One of the nation’s largest hospital networks adopts vascular robotic technology in multiple hospital locations to treat patients in need of...

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

Expanded indication provides access to robotic technology in vascular procedures from head to toe Corindus Vascular Robotics, Inc. [NYSE...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

CVRS - Frequently Asked Questions (FAQ)

What is the current Corindus Vascular Robotics Inc share price?

The current share price of Corindus Vascular Robotics Inc is US$ 4,27

What is the 1 year trading range for Corindus Vascular Robotics Inc share price?

Corindus Vascular Robotics Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Corindus Vascular Robotics Inc (CVRS)

Corindus Vascular Robotics Inc (CVRS) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

CVRS Dernières nouvelles

Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc.

Corindus Reports Second Quarter 2019 Results

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

CVRS - Frequently Asked Questions (FAQ)

CVRS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Corindus Vascular Robotics Inc (CVRS)

Corindus Vascular Robotics Inc (CVRS) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

CVRS Dernières nouvelles

Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference

First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine

SHAREHOLDER ALERT: WeissLaw LLP Investigates Corindus Vascular Robotics, Inc.

Corindus Reports Second Quarter 2019 Results

Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers

Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities

Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand

CVRS - Frequently Asked Questions (FAQ)

CVRS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS